EGFR and cancer: A combination of nanobody-mediated NIR-PIT, which targets vascular endothelial growth factor receptor 2 (VEGFR2) on tumor endothelial cells, and EGFR on tumor cells, has also shown improved efficacy in a coculture model of endothelial and cancer cells 87.